Rankings
▼
Calendar
LSTA Q1 2023 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
LSTA
Lisata Therapeutics, Inc.
$44M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$6M
EPS (Diluted)
$-0.77
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$675,000
Balance Sheet
Total Assets
$66M
Total Liabilities
$6M
Stockholders' Equity
$61M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$7M
-$7M
-3.4%
Net Income
-$6M
-$4M
-46.4%
← FY 2023
All Quarters
Q2 2023 →